otiti
media
om
inflamm
middl
ear
compris
middl
ear
caviti
ossicl
fig
umbrella
term
encapsul
acut
om
aom
om
effus
ome
glue
ear
chronic
suppur
om
csom
tabl
condit
close
relat
overlap
om
one
common
diseas
young
children
highincom
countri
also
lead
caus
medic
consult
antibiot
prescript
aom
character
presenc
fluid
middl
ear
middl
ear
effus
mee
togeth
sign
symptom
acut
mani
children
occasion
aom
subset
children
recurr
episod
tabl
recurr
episod
aom
caus
frequent
episod
acut
ear
pain
fever
gener
ill
consider
distress
children
parent
suppur
pusform
complic
aom
includ
acut
mastoid
mening
brain
abscess
rare
given
high
incid
aom
potenti
seriou
complic
pose
threat
lowincom
countri
estim
peopl
die
complic
om
everi
global
preval
hear
loss
associ
om
estim
rang
per
perfor
tympan
membran
eardrum
occur
local
sequela
aom
complic
associ
treatment
ventil
tympanostomi
tube
ome
character
presenc
mee
behind
intact
tympan
membran
contrast
aom
ome
associ
sign
symptom
acut
main
symptom
ome
conduct
hear
loss
caus
impair
transduct
sound
wave
middl
ear
due
presenc
mee
hear
loss
persist
recur
frequent
may
neg
impact
languag
behaviour
progress
ome
common
children
one
episod
ome
year
age
ome
may
occur
newonset
ome
viral
aom
inflammatori
process
subsid
mee
persist
fact
aom
episod
children
ome
ome
risk
factor
aom
demonstr
interrelated
condit
csom
defin
chronic
inflamm
middl
ear
mastoid
caviti
persist
recurr
ear
discharg
tympan
membran
perfor
ventil
tube
promin
csom
caus
conduct
hear
loss
might
damag
middl
ear
ossicl
also
increas
risk
perman
sensorineur
hear
loss
hear
loss
due
damag
inner
ear
intracrani
preval
condit
vari
wide
countri
common
lowincom
middleincom
sinc
public
landmark
review
om
decad
import
develop
worldwid
made
particular
regard
prevent
om
pneumococc
conjug
vaccin
treatment
om
follow
new
guidelin
focu
accur
diagnosi
judici
use
antibiot
event
modifi
epidemiolog
clinic
pictur
om
worldwid
primer
provid
stateoftheart
review
om
epidemiolog
underli
pathophysiolog
diagnosi
impact
children
famili
prevent
treatment
option
also
discuss
promis
futur
direct
om
research
might
guid
clinician
carer
optim
health
wellb
young
children
om
recent
systemat
review
global
burden
om
estim
averag
aom
incid
rate
new
episod
per
peopl
per
rate
rang
averag
central
europ
averag
subsaharan
west
africa
central
africa
reflect
burden
aom
vari
econom
statu
fig
total
annual
number
new
aom
episod
estim
million
occur
children
year
age
global
aom
incid
rate
highest
children
year
age
new
episod
per
children
per
year
peak
incid
first
year
life
new
episod
per
children
per
year
ome
asymptomat
may
go
undetect
incid
preval
difficult
establish
accur
reliabl
data
epidemiolog
ome
come
larg
cohort
studi
children
develop
countri
mostli
perform
show
point
preval
ome
screen
test
peak
incid
ome
around
year
age
year
age
almost
children
experienc
least
one
episod
csom
averag
global
incid
rate
estim
new
episod
per
peopl
age
per
fig
total
annual
number
new
csom
episod
estim
million
occur
children
year
age
global
csom
incid
rate
highest
first
year
life
new
case
per
children
per
year
recent
studi
unit
suggest
declin
om
incid
sinc
declin
attribut
introduct
clinic
guidelin
recommend
stricter
diagnost
criteria
judici
use
antibiot
om
well
introduct
pneumococc
conjug
vaccin
contrast
studi
develop
countri
indigen
popul
continu
demonstr
heavi
burden
om
particularli
csom
risk
om
significantli
influenc
numer
host
environment
factor
fig
host
factor
increas
risk
om
includ
young
male
race
genet
factor
famili
histori
craniofaci
anomali
cleft
upper
respiratori
tract
infect
urti
adenoid
laryngopharyng
environment
factor
increas
risk
om
includ
low
socioeconom
statu
exposur
tobacco
older
daycar
use
breastf
protect
develop
countri
malnutrit
contamin
water
poor
hygien
overcrowd
human
immunodefici
viru
infect
tuberculosi
malaria
poor
access
health
care
increas
risk
chronic
complic
anatom
function
eustachian
tube
contribut
protect
middl
ear
influx
bacteri
otopathogen
respiratori
virus
also
essenti
drainag
secret
middl
ear
space
pressur
inde
anatomi
immatur
eustachian
tube
infant
central
role
suscept
infect
middl
ear
fig
eustachian
tube
epithelium
frontlin
defenc
passag
colon
otopathogen
nasopharynx
eustachian
tube
epithelium
predominantli
consist
ciliat
respiratori
epitheli
cell
produc
antimicrobi
protein
lysozym
interspers
goblet
cell
produc
mucoid
serou
mucu
direct
mucociliari
flow
middl
ear
eustachian
tube
nasopharynx
combin
epitheli
secret
antimicrobi
protein
protect
bacteri
colon
middl
ear
anatom
eustachian
tube
shorter
wider
horizont
infant
young
children
year
age
adult
facilit
otopathogen
transmiss
middl
ear
increas
risk
frequent
placement
infant
supin
posit
also
exacerb
infect
risk
children
grow
skull
base
extend
downward
increas
angl
eustachian
tube
gradual
approxim
birth
adult
concurr
length
eustachian
tube
increas
mm
anatom
chang
well
function
matur
immun
system
might
contribut
reduc
risk
om
children
age
even
children
high
risk
om
earli
colon
nasopharynx
bacteri
otopathogen
consider
increas
risk
subsequ
episod
streptococcu
pneumonia
pneumococcu
nontyp
haemophilu
influenza
moraxella
catarrhali
three
domin
bacteri
otopathogen
report
global
individu
speci
strain
domin
influenc
geograph
locat
pneumococc
conjug
vaccin
pcv
exampl
indigen
australian
children
month
age
like
two
otopathogen
isol
nasopharynx
nonindigen
australian
children
indigen
australian
children
earli
carriag
nontyp
h
influenza
increas
risk
om
wherea
nonindigen
australian
children
earli
carriag
catarrhali
associ
increas
risk
om
differ
indigen
nonindigen
australian
children
like
result
differ
environment
risk
studi
examin
correl
bacteri
densiti
load
nasopharynx
om
focus
children
specif
risk
develop
nevertheless
studi
show
bacteri
densiti
nasopharynx
associ
increas
risk
om
bacteri
biofilm
colon
bacteria
embed
extracellular
matrix
adher
surfac
known
protect
bacteria
antibiot
host
immun
respons
demonstr
middl
ear
patient
persist
om
fail
antibiot
biofilm
report
occur
attach
middl
ear
anim
immun
nontyp
h
influenza
result
morerapid
resolut
establish
biofilm
suggest
vaccin
induc
immun
respons
effect
pathogen
resid
biofilm
middl
ear
aom
alway
preced
viral
infect
nasopharyng
eustachian
tube
epithelium
common
cold
viral
fig
bacteri
otopathogen
colon
nasopharynx
caus
harm
viru
initi
inflammatori
process
nasopharynx
wide
varieti
virus
caus
urti
symptom
induc
aom
develop
includ
follow
virus
order
import
respiratori
syncyti
viru
rsv
rhinoviru
adenoviru
coronaviru
bocaviru
influenza
viru
parainfluenza
viru
enteroviru
human
viral
infect
creat
chang
nasopharyng
mucosa
modifi
host
immun
induc
cytokin
activ
inflammatori
increas
bacteri
colon
adher
upregul
host
cell
surfac
antigen
serv
bacteri
receptor
viral
infect
also
alter
properti
mucu
diminish
normal
mucociliari
clearanc
mucos
cell
eustachian
tube
nasopharynx
caus
tubal
lead
neg
middl
ear
pressur
occur
sever
children
month
age
children
month
neg
middl
ear
pressur
facilit
influx
bacteria
andor
virus
middl
risk
aom
develop
urti
depend
colon
bacteri
otopathogen
risk
lowest
colon
bacteria
highest
colon
three
pathogen
presenc
live
virus
middl
ear
addit
bacteria
associ
increas
inflammatori
mediat
cytokin
histamin
leukotrien
turn
interfer
antibiot
penetr
middl
viru
alon
caus
aom
experiment
anim
approxim
mee
isol
children
aom
contain
aom
follow
viral
urti
often
occur
infect
sever
enough
caus
urti
symptom
associ
eustachian
tube
dysfunct
asymptomat
viral
infect
lead
viral
infect
lead
aom
also
newonset
ome
children
peak
age
incid
om
month
rate
aom
ome
follow
urti
innat
immun
bacteria
virus
induc
middl
ear
inflamm
innat
immun
system
includ
physic
barrier
mucocillari
gener
flow
mucu
innat
defenc
molecul
lysozym
defensin
complement
factor
cytokin
system
respons
initi
frontlin
respons
pathogen
nasopharynx
eustachian
tube
middl
ear
activ
pattern
recognit
receptor
particularli
tolllik
receptor
tlr
invad
otopathogen
trigger
releas
sever
antimicrobi
protein
proinflammatori
upregul
innat
mechan
crucial
rapid
resolut
howev
cytokin
antimicrobi
protein
also
pathophysiolog
character
persist
inflamm
middl
ear
observ
predomin
bacteri
pathogen
csom
pseudomona
aeruginosa
staphylococcu
form
biofilm
otopathogen
elicit
increas
innat
inflammatori
respons
might
contribut
chronic
om
progress
csom
despit
appropri
evid
increas
inflamm
includ
high
level
middl
ear
increas
mrna
protein
level
tumour
necrosi
factor
tnf
middl
ear
mucosa
compar
patient
chronic
adapt
immun
middl
ear
effect
immunocompet
site
maintain
essenti
steril
environ
adapt
immun
respons
reflect
aspect
mucos
system
immun
inde
antigenspecif
secretori
iga
igg
antibodi
detect
middl
ear
fluid
igaproduc
cell
detect
middl
ear
mucosa
respons
infect
research
commenc
middl
ear
cellmedi
respons
infect
earli
data
indic
regulatori
cell
may
play
pivot
part
control
inflamm
literatur
unclear
whether
defici
humor
immun
contribut
suscept
om
research
requir
explor
aberr
adapt
immun
respons
potenti
risk
factor
suscept
estim
herit
aom
ome
rang
boy
slightli
higher
risk
rang
gene
regul
innat
immun
respons
associ
predisposit
herit
risk
om
might
result
cytokin
polymorph
specif
otopathogen
exampl
polymorph
tnf
predict
om
coincid
rsv
rhinoviru
wherea
polymorph
sever
signal
transduct
pathway
tlr
signal
associ
risk
diseas
sever
om
human
studi
mous
polymorph
describ
date
disrupt
establish
effect
innat
immun
respons
polymorph
transform
growth
signal
pathway
pathophysiolog
interfer
moder
proinflammatori
although
data
respect
defici
specif
antibodi
respons
otopathogen
children
prone
om
conflict
role
possibl
cellmedi
dysfunct
becom
clearer
genet
contribut
observ
unknown
possibl
interact
might
role
research
need
fulli
understand
role
genet
factor
pathogenesi
om
sign
symptom
obtain
patient
histori
includ
earspecif
nonspecif
symptom
tabl
rais
suspicion
om
insuffici
accur
diagnosi
exampl
typic
sign
symptom
aom
might
absent
ome
definit
sign
symptom
acut
ear
infect
children
asymptomat
lessobvi
sign
hear
problem
subtl
find
ear
rub
clumsi
disturb
sleep
languag
delay
poor
school
ear
pain
consist
symptom
aom
children
aom
complain
ear
young
preverb
children
ear
pain
may
manifest
ear
manipul
exampl
tug
rub
hold
excess
cri
chang
sleep
behaviour
pattern
howev
symptom
nonspecif
like
fever
vomit
differenti
children
aom
mee
requir
diagnos
aom
ome
absenc
preclud
diagnosi
aom
howev
difficulti
confirm
mee
primari
care
set
help
explain
aom
wide
contrast
ome
might
underdiagnos
paediatrician
compar
ear
discharg
visibl
discharg
extern
ear
canal
present
aom
acut
tympan
membran
perfor
drain
ventil
tube
csom
chronic
tympan
membran
perfor
persist
drainag
acut
otiti
externa
inflamm
extern
ear
canal
bulg
tympan
membran
visual
otoscopi
key
diagnost
featur
aom
diagnos
otoscopi
assess
use
symptom
sever
scale
pneumat
otoscopi
primari
diagnost
modal
ome
otomicroscopi
tympanometri
adjunct
measur
acoust
reflectometri
use
parent
assess
mee
tympan
membran
perfor
associ
csom
may
diagnos
otoscopi
otomicroscopi
may
requir
remov
ear
discharg
suction
adequ
visual
symptom
sever
scale
aom
sever
valid
parentreport
symptom
scale
develop
assess
aom
sever
aom
sever
symptom
scale
aomso
scale
respons
option
littl
lot
preval
past
hour
ear
pain
ear
tug
irrit
difficulti
sleep
eat
less
less
play
overal
aomso
score
discrimin
among
children
aom
without
aom
sign
symptom
present
vari
degre
children
normal
anoth
sever
measur
aom
face
scale
aomf
use
scale
seven
choic
rang
present
problem
extrem
problem
otoscopi
otoscopi
mainstay
aom
diagnosi
fig
tabl
obstruct
cerumen
earwax
prevent
adequ
visual
tympan
membran
must
remov
facilit
accur
perform
otoscopi
clinician
assess
record
tympan
membran
colour
opac
posit
integr
bulg
tympan
membran
associ
high
level
bacteri
pathogen
consist
sign
fig
use
featur
differenti
aom
bulg
subsid
tympan
membran
may
cobbleston
appear
shagrin
opaqu
cloudi
tympan
membran
highli
predict
mee
regardless
sever
imagebas
scale
exist
standard
record
interpret
otoscop
pneumat
otoscopi
pneumat
otoscopi
recommend
primari
diagnost
method
tabl
excel
diagnost
otoscopi
alon
without
pneumat
bulb
might
overlook
ome
tympan
membran
might
appear
normal
earrel
symptom
minim
absent
convers
pneumat
otoscopi
avoid
falseposit
diagnos
ome
caus
surfac
abnorm
tympan
membran
without
distinctli
impair
mobil
tympan
membran
pneumat
otoscopi
highli
predict
improv
diagnost
accuraci
otoscopi
howev
use
pneumat
otoscopi
clinic
practic
variabl
worldwid
unit
state
alon
preval
rang
train
medic
resid
pneumat
otoscopi
enhanc
structur
computer
curriculum
static
dynam
imag
tympan
otomicroscopi
otomicroscopi
might
help
simpl
otoscopi
diagnos
tabl
evid
spars
need
special
equip
train
often
limit
examin
secondari
care
otomicroscopi
use
assess
tympan
membran
abnorm
perfor
atrophi
tympanosclerosi
atelectasi
retract
pocket
may
associ
chronic
tympanometri
tympanometri
object
measur
tympan
membran
mobil
middl
ear
fig
tabl
compar
pneumat
otoscopi
tympanometri
compar
sensit
rang
lower
specif
versu
tympanometri
pneumat
otoscopi
respect
diagnos
barrier
tympanometri
primari
care
set
includ
equip
cost
limit
train
tympanometri
easier
perform
use
manag
children
om
pneumat
tympanometri
also
estim
equival
ear
canal
volum
defin
amount
air
front
probe
normal
ml
low
equival
volum
ml
could
indic
inaccur
read
ear
canal
obstruct
cerumen
probe
press
canal
wall
high
equival
volum
ml
occur
tympan
membran
intact
perfor
ventil
tube
prompt
examin
neither
initi
suspect
tympanometri
gener
perform
use
hz
tone
children
month
age
hz
probe
tone
best
hz
tone
insensit
acoust
reflectometri
acoust
reflectometri
measur
much
sound
reflect
tympan
membran
higher
reflect
indic
greater
probabl
tabl
advantag
tympanometri
includ
eas
use
requir
hermet
seal
avail
inexpens
consum
version
use
reliabl
parent
monitor
middl
ear
statu
reflectometri
studi
less
tympanometri
detect
mee
high
specif
neg
predict
valu
make
reflectometri
use
rule
mee
children
om
multifactori
diseas
variou
strategi
use
prevent
strategi
mainli
focu
reduc
modifi
risk
factor
bacteri
viral
infect
environment
risk
chemoprophylaxi
use
antibiot
surgic
intervent
reduc
burden
om
children
discuss
manag
section
vaccin
direct
bacteri
otopathogen
goal
vaccin
reduc
elimin
nasopharyng
colon
pneumonia
nontyp
h
influenza
catarrhali
sevenval
pcv
direct
seven
serotyp
pneumonia
becam
avail
unit
state
mani
european
countri
vaccin
ad
primari
seri
univers
vaccin
month
booster
dose
month
associ
reduct
aom
caus
pneumococc
serotyp
contain
vaccin
reduct
overal
aom
reduct
use
ventil
tube
chronic
recurr
avail
decad
later
associ
reduct
aom
mastoid
ventil
tube
use
pcv
led
replac
serotyp
pneumonia
nasopharynx
serotyp
cover
vaccin
nontyp
h
influenza
vaccin
nevertheless
pneumococcalassoci
aom
may
continu
decreas
pneumococc
conjug
vaccin
serotyp
greater
capac
caus
aom
replac
lessotopathogen
also
grow
evid
support
hypothesi
least
develop
countri
prevent
om
associ
pneumococc
serotyp
present
vaccin
young
children
result
reduct
subsequ
morecomplex
diseas
caus
nonvaccin
serotyp
nontyp
h
influenza
vaccin
might
therefor
disrupt
continuum
evolut
pneumococcalassoci
om
toward
chronic
howev
commun
earli
dens
bacteri
acquisit
nasopharynx
geograph
region
oceania
nontyp
h
influenza
may
primari
importantli
pcv
prevent
om
episod
vaccin
occur
recurr
aom
nontyp
h
influenza
protein
carrier
protein
design
protect
pneumonia
nontyp
h
influenza
avail
europ
although
effect
pneumococcalassoci
om
may
less
protect
nontyp
h
influenza
origin
report
prototyp
vaccin
licens
vaccin
nontyp
h
influenza
catarrhali
exist
numer
vaccin
variou
stage
develop
vaccin
direct
respiratori
virus
aom
gener
preced
symptomat
viral
prevent
viral
urti
may
make
impact
aom
incid
date
avail
vaccin
viral
respiratori
infect
influenza
viru
trival
influenza
vaccin
protect
three
influenza
viru
strain
inactiv
influenza
vaccin
live
attenu
influenza
vaccin
shown
reduc
aom
flu
vaccin
work
prevent
influenza
viru
infect
influenzaassoci
aom
occur
twothird
young
children
influenza
viru
effect
aom
prevent
vari
year
year
depend
level
influenza
activ
commun
well
match
vaccin
circul
strain
recommend
influenza
vaccin
children
vari
worldwid
influenza
vaccin
recommend
children
month
age
unit
wherea
recommend
restrict
children
year
age
unit
restrict
children
substanti
medic
comorbid
includ
respiratori
cardiovascular
metabol
renal
diseas
nonvaccin
approach
prevent
viral
urti
aom
aom
occur
mostli
day
urti
thu
earli
administr
antivir
uncompl
urti
may
prevent
aom
studi
shown
reduct
develop
aom
young
children
treat
oseltamivir
within
hour
influenza
symptom
howev
recent
metaanalysi
children
adult
data
conclud
neither
oseltamivir
zanamivir
significantli
reduc
risk
echinacea
immun
modul
mild
antivir
often
use
home
remedi
report
reduc
risk
recurr
respiratori
infect
includ
virolog
confirm
case
xylitol
fivecarbon
natur
occur
sugar
alcohol
antibacteri
properti
shown
prevent
recurr
aom
howev
success
dose
regimen
chew
gum
syrup
given
five
time
per
day
continu
month
practic
probiot
mostli
lactobacillu
bifidobacterium
use
reduc
risk
respiratori
symptom
om
result
encourag
warrant
environment
risk
factor
avoid
wellknown
environment
risk
daycar
attend
exposur
tobacco
smoke
use
pacifi
especi
om
peak
age
incid
month
associ
reduct
convers
benefit
breastfeed
prevent
om
long
known
breastfeed
protect
om
first
year
protect
greater
exclus
breastf
breastf
long
durat
month
current
guidanc
recommend
avoid
tobacco
smoke
exposur
recommend
exclus
breastfeed
month
discuss
lifestyl
chang
avoid
supin
bottl
feed
reduc
use
pacifi
consid
altern
child
care
arrang
exampl
smaller
group
use
child
minder
symptomat
manag
ear
pain
fever
analges
appropri
ageadjust
dose
mainstay
aom
oral
paracetamol
ibuprofen
effect
reliev
ear
topic
analges
might
provid
addit
brief
benefit
current
evid
effect
reliev
ear
pain
ongo
uk
trial
assess
clinic
costeffect
ear
drop
contain
combin
benzocain
phenazon
compar
placebo
drop
drop
children
year
age
present
primari
care
oral
antibiot
reduc
durat
aom
symptom
consecut
mee
lead
advers
effect
gastrointestin
symptom
skin
routin
use
condit
common
aom
also
enhanc
risk
antimicrobi
resist
commun
well
individu
aom
run
favour
natur
cours
children
otherwis
healthi
symptom
settl
within
day
complic
rare
benefit
cost
antibiot
treatment
need
care
benefit
promin
children
year
age
bilater
aom
age
present
acut
ear
discharg
due
thu
current
guidanc
recommend
consid
immedi
antibiot
immedi
antibiot
treatment
recommend
aom
month
age
immunocompromis
craniofaci
malform
well
sever
ill
due
children
uncompl
nonsever
aom
increas
risk
complic
watch
wait
delay
antibiot
prescript
file
symptom
aom
persist
hour
recommend
watch
wait
involv
care
monitor
diseas
cours
caregiv
specif
instruct
return
case
persist
symptom
worsen
child
limit
evid
suggest
amoxicillin
without
clavulan
acid
effect
macrolid
therefor
firstlin
treatment
cefdinir
cefuroxim
clarithromycin
recommend
altern
patient
penicillin
choos
appropri
antibiot
regimen
import
local
antimicrobi
resist
pattern
taken
account
topic
oral
decongest
antihistamin
corticosteroid
either
proven
effect
shown
conflict
result
resolv
symptom
aom
therefor
tympanocentesi
myringotomi
small
incis
tympan
membran
allow
fluid
drain
middl
ear
may
role
determin
pathogen
caus
aom
ineffect
treatment
modal
manag
children
recurr
aom
focus
prevent
aom
episod
although
immun
pcv
earli
infanc
proven
effect
reduc
risk
child
develop
recurr
vaccin
longer
effect
children
establish
recurr
antibiot
prophylaxi
children
recurr
aom
reduc
number
aom
recurr
per
year
recurr
howev
use
recommend
given
advers
effect
associ
prolong
antibiot
treatment
emerg
antibiot
resist
role
ventil
tube
manag
children
recurr
aom
fulli
establish
fig
evid
benefit
ventil
tube
mainli
avail
first
month
insert
approxim
one
aom
episod
prevent
magnitud
effect
although
definit
current
evid
regard
natur
histori
treatment
benefit
suggest
ventil
tube
help
recurr
aom
without
persist
mee
appropri
option
manag
recurr
aom
persist
mee
one
ear
time
assess
tube
adenoid
serv
nasopharyng
reservoir
respiratori
pathogen
enlarg
may
caus
obstruct
nasal
airway
impair
eustachian
tube
function
adenoidectomi
surgic
remov
adenoid
practic
children
recurr
aom
improv
middl
ear
function
therebi
prevent
aom
episod
recent
metaanalysi
combin
individu
patient
data
ten
trial
shown
recurr
aom
adenoidectomi
standalon
oper
adjunct
ventil
tube
insert
benefici
children
year
howev
magnitud
effect
surgic
intervent
modest
benefit
care
balanc
harm
associ
surgic
procedur
main
sign
symptom
ome
hear
loss
thu
manag
ome
primarili
aim
allevi
restor
hear
ome
settl
spontan
mani
children
within
sever
medic
treatment
decongest
antihistamin
intranas
corticosteroid
either
ineffect
may
caus
advers
consequ
current
guidelin
recommend
period
watch
wait
children
ome
particular
risk
speech
languag
learn
ventil
tube
option
children
ome
still
document
hear
difficulti
adenoidectomi
standalon
oper
adjunct
tube
insert
benefici
children
ome
year
subgroup
children
adjuv
adenoidectomi
shown
reduc
need
ventil
tube
reinsert
around
compar
tube
role
hear
aid
allevi
hear
loss
children
ome
hear
aid
current
recommend
children
persist
bilater
ome
surgeri
contraind
recent
nasal
balloon
autoinfl
shown
effect
clear
mee
improv
ear
symptom
month
schoolag
children
present
primari
care
recent
onset
howev
effect
observ
modest
number
need
treat
benefit
nine
patient
cost
per
case
whether
approach
reduc
need
ventil
tube
yet
answer
appli
ongo
uk
trial
assess
clinic
effect
costeffect
cours
oral
corticosteroid
children
year
age
persist
bilater
ome
hear
balloon
dilat
eustachian
tube
propos
novel
treatment
children
persist
ome
howev
evid
yet
support
manag
mani
children
ventil
tube
develop
episod
acut
ear
discharg
report
incid
rate
rang
episod
may
accompani
foul
odour
pain
fever
reduc
qualiti
life
qol
child
thought
result
aom
middl
ear
fluid
drain
tube
risk
factor
includ
young
age
recurr
aom
indic
tube
recent
histori
recurr
urti
presenc
older
format
bacteri
biofilm
ventil
tube
may
also
role
particularli
ear
discharg
recur
becom
chronic
episod
ear
discharg
occur
immedi
postop
period
later
stage
manag
therefor
focus
either
prevent
earli
stage
treatment
episod
occur
later
stage
mani
periop
intervent
test
shown
benefit
prevent
earli
postop
ear
discharg
salin
washout
middl
ear
applic
antibiot
without
corticosteroid
ear
drop
tube
surgeri
use
topic
system
antibiot
earli
postop
largest
effect
intervent
found
studi
risk
children
develop
earli
postop
ear
discharg
bacteri
otopathogen
commonli
found
acut
ear
discharg
occur
beyond
immedi
postop
period
children
ventil
tube
h
influenza
aureu
p
aeruginosa
infect
ototop
antibiot
formul
cover
pathogen
howev
concern
potenti
ototox
advers
effect
use
patient
nonintact
tympan
membran
prompt
mani
physician
treat
children
system
antibiot
quinolon
antibiot
ear
drop
far
shown
ototox
recommend
unit
state
system
base
recent
landmark
trial
show
ear
drop
contain
combin
antibiot
corticosteroid
clinic
effect
costeffect
manag
strategi
children
develop
uncompl
acut
ear
discharg
beyond
immedi
postop
current
guidanc
recommend
ototop
antibiot
drop
firstlin
treatment
evid
ear
drop
contain
combin
antibiot
corticosteroid
superior
contain
antibiot
topic
quinolon
shown
effect
drug
treatment
topic
antisept
system
antibiot
clear
csomrel
aural
discharg
short
term
week
current
evid
assess
effect
quinolonecontain
versu
nonquinolonecontain
eardrop
quinolon
advantag
limit
evid
suggest
treat
patient
csom
combin
system
topic
antibiot
effect
topic
antibiot
two
review
compar
two
differ
autolog
graft
materi
repair
tympan
membran
perfor
temporali
muscl
fascia
tympanoplasti
cartilag
tympanoplasti
found
fewer
postop
tympan
membran
perfor
cartilag
graft
differ
term
tradit
articl
focus
impact
om
term
polici
focus
econom
burden
relev
health
care
exampl
us
billion
annual
unit
field
medicin
formal
measur
qol
patient
om
came
late
date
mostli
clinician
research
focu
captur
effect
om
om
manag
diseasespecif
symptom
effect
qol
consequ
mani
instrument
label
qol
fact
om
symptom
score
map
score
gener
qol
chang
scale
level
gener
measur
pattern
associ
particular
challeng
measur
gener
qol
om
expect
small
effect
size
om
common
often
mild
diseas
inaccuraci
owe
inevit
delay
document
essenti
paramet
persist
episod
condit
om
need
proxi
parent
carer
om
variou
valid
qol
instrument
avail
short
questionnair
suitabl
routin
audit
use
clinic
set
longer
indepth
instrument
moreintens
qol
research
effici
follow
item
format
maxim
gener
ecolog
valid
per
item
low
burden
respond
consequ
leav
ambigu
detail
present
profil
moretradit
instrument
ref
short
form
ref
csom
support
three
five
score
breviti
item
limit
precis
reliabl
henc
studi
power
given
use
larg
sampl
size
breviti
still
permit
posit
find
avoid
falseneg
error
may
leav
true
scope
effect
size
uncertain
nevertheless
breviti
encourag
widespread
routin
adopt
advent
largescal
data
registri
creat
opportun
miss
routin
use
questionnair
clinic
set
provid
use
link
research
practic
gener
tradit
pictur
ome
semisymptomat
major
concern
hear
loss
consequ
problem
speech
languag
commun
social
engag
school
behaviour
readili
demonstr
descript
studi
rather
health
sequela
larg
gener
although
total
comprehens
gener
qol
literatur
qol
patient
ome
prefer
cognit
academ
perform
measur
exampl
larg
longitudin
cohort
studi
found
conjunct
synerg
om
histori
poor
environ
social
develop
gave
worst
outcom
import
school
qol
knockon
effect
academ
problem
gener
qol
would
expect
quantit
studi
yet
done
demonstr
link
directli
among
children
year
age
therefor
highli
reliabl
gener
health
show
consist
deficit
subscal
qol
even
without
concurr
activ
om
small
uncontrol
studi
manag
ome
pervas
qol
improv
measur
claim
insert
ventil
tube
compar
interpret
unclear
limit
treatment
literatur
suggest
effect
intervent
necessarili
result
measur
magnitud
qol
larg
studi
among
children
chronic
recurr
om
show
children
recurr
aom
combin
recurr
aom
ome
score
wors
four
six
domain
item
scale
physic
suffer
emot
distress
activ
limit
caregiv
concern
children
ome
children
histori
om
diagnos
primari
secondari
care
number
aom
episod
found
strong
determin
primari
carebas
cohort
studi
confirm
sleep
disturb
import
correl
loss
qol
parent
children
recurr
clinic
popul
children
recurr
aom
effect
gener
qol
equal
comparison
group
children
use
measur
magnitud
impact
two
studi
address
effect
fact
qol
questionnair
complet
proxi
caregiv
given
qol
caregiv
also
affect
om
episod
distinct
effect
number
episod
reduct
qol
caregiv
insert
ventil
tube
children
recurr
aom
combin
recurr
aom
ome
result
import
improv
recent
trial
show
reduct
episod
adenoidectomi
lead
measur
correspond
improv
qol
young
children
recurr
vaccin
improv
specif
gener
qol
studi
need
examin
relationship
environment
risk
factor
bacteri
densiti
nasopharynx
bacteri
biofilm
format
genet
om
particularli
respect
diseas
sever
specif
interact
bacteria
virus
nasopharynx
may
enhanc
risk
aom
futur
research
focu
interplay
virus
bacteria
better
understand
complex
mechan
could
lead
new
bacteri
viral
vaccin
would
help
reduc
burden
aom
current
research
ongo
focus
innat
immun
respons
interact
otopathogen
better
understand
balanc
process
effect
recoveri
infect
versu
facilit
chronic
inflamm
wherea
numer
genet
polymorph
describ
gene
encod
protein
involv
innat
immun
clinic
relev
risk
sever
diseas
still
unknown
children
improv
understand
interact
host
innat
immun
system
otopathogen
may
lead
wider
rang
treatment
aom
tend
overdiagnos
thu
overtr
especi
primari
care
set
owe
difficulti
confirm
improv
mee
diagnosi
requir
work
determin
optim
method
teach
pneumat
otoscopi
traine
clinician
develop
costeffect
method
accur
detect
mee
handheld
ultrasonographi
tympanometri
devic
multifrequ
tympanometri
wideband
acoust
transfer
function
promis
technolog
identifi
middl
ear
disord
limit
evid
restrict
conclus
diagnost
futur
research
need
investig
whether
techniqu
provid
ad
valu
current
diagnost
test
thu
far
investig
studi
biomark
serum
nasopharyng
secret
correl
aom
diagnosi
type
bacteria
virus
outcom
high
serum
level
intercellular
adhes
molecul
found
children
aom
compar
healthi
time
aom
onset
serum
level
increas
return
normal
children
aom
high
serum
concentr
granulocyt
colonystimul
factor
predict
rsvinduc
aom
wherea
high
concentr
predict
earli
clinic
failur
antibiot
increas
serum
concentr
associ
pneumococcalinduc
serum
biomark
risk
score
develop
predict
presenc
recoveri
aom
caus
nontyp
h
nasopharyng
secret
lactat
dehydrogenas
concentr
associ
risk
aom
develop
viral
togeth
data
indic
specif
system
local
biomark
help
predict
aom
develop
microbiolog
clinic
outcom
studi
requir
explor
biomark
evalu
use
biomark
determin
clinic
practic
although
vaccin
pneumonia
associ
declin
incid
om
widespread
use
pcv
associ
shift
pneumococc
serotyp
increas
import
nontyp
h
influenza
caus
need
effect
pneumococc
vaccin
cover
serotyp
effect
vaccin
h
influenza
catarrhali
theori
proteinbas
vaccin
would
simpler
less
costli
produc
conjug
vaccin
sever
protein
vaccin
antigen
pneumonia
h
influenza
catarrhali
variou
stage
develop
licens
vaccin
addit
far
influenza
viru
vaccin
viral
vaccin
shown
efficaci
om
futur
goal
prevent
om
prevent
viral
urti
need
includ
vaccin
virus
consider
effort
made
develop
rsv
vaccin
numer
rsv
vaccin
phase
phase
ii
work
need
establish
whether
viral
vaccin
abl
prevent
probiot
use
prevent
om
encourag
studi
requir
identifi
promis
probiot
strain
elucid
mechan
probiot
prevent
om
recent
systemat
review
provid
overview
global
microbiolog
aom
ome
ref
clear
region
tempor
differ
influenc
introduct
pcv
henc
import
ongo
microbi
surveil
introduc
monitor
shift
caus
otopathogen
remark
trial
far
om
exclud
children
prone
condit
syndrom
craniofaci
malform
cleft
palat
highqual
studi
evalu
use
screen
ome
effect
variou
manag
strategi
atrisk
children
prioriti
current
approach
need
work
includ
topic
antibiot
aom
ear
discharg
due
spontan
tympan
membran
perfor
topic
antibiot
approach
proven
effect
children
ventil
uncertain
result
also
applic
children
without
addit
ongo
research
transtympan
deliveri
drug
without
tympan
membran
perfor
tube
promis
chinchilla
model
applic
antibioticcontain
ciprofloxacin
gel
tympan
membran
achiev
antibiot
concentr
middl
ear
fluid
adequ
aom
work
need
establish
method
applic
practic
effect
human
role
hear
aid
acoust
approach
soundfield
amplif
manag
children
ome
current
unresolv
urgent
need
highqual
evid
particularli
atrisk
csom
variou
novel
adjuv
treatment
test
aim
enhanc
repair
tympan
membran
perfor
includ
biomolecul
stimul
growth
perfor
edg
bioengin
work
necessari
establish
role
treatment
clinic
practic
across
area
epidemiolog
prevent
treatment
om
import
clinician
research
agre
diseas
definit
studi
methodolog
core
outcom
measur
result
pool
contrast
across
futur
studi
inform
see
http
wwwcometinitiativeorg
http
wwwichomorg
http
wwwidealcollaborationnet
http
wwwinvoorguk
recent
recommend
made
outcom
measur
studi
manag
ome
children
cleft
encourag
develop
core
outcom
set
patient
group
manifest
om
includ
gener
impact
strongli
recommend
parent
children
systemat
consult
appropri
level
detail
goal
involv
plan
process
well
stage
research
om
ad
relev
children
om
carer
highqual
research
statist
power
freedom
confound
given
addit
capac
chang
practic
better
